- Home
- GHRS vs NVGS Comparison
GHRS vs NVGS Comparison
Compare GHRS & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- NVGS
- Stock Information
- Founded
- GHRS 2018
- NVGS 1997
- Country
- GHRS Ireland
- NVGS United Kingdom
- Employees
- GHRS N/A
- NVGS N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- NVGS Marine Transportation
- Sector
- GHRS Health Care
- NVGS Consumer Discretionary
- Exchange
- GHRS Nasdaq
- NVGS Nasdaq
- Market Cap
- GHRS 849.8M
- NVGS 994.3M
- IPO Year
- GHRS 2021
- NVGS N/A
- Fundamental
- Price
- GHRS $12.06
- NVGS $14.35
- Analyst Decision
- GHRS Strong Buy
- NVGS Strong Buy
- Analyst Count
- GHRS 8
- NVGS 3
- Target Price
- GHRS $30.63
- NVGS $22.00
- AVG Volume (30 Days)
- GHRS 176.0K
- NVGS 661.3K
- Earning Date
- GHRS 05-08-2025
- NVGS 08-13-2025
- Dividend Yield
- GHRS N/A
- NVGS 1.38%
- EPS Growth
- GHRS N/A
- NVGS 9.28
- EPS
- GHRS N/A
- NVGS 1.27
- Revenue
- GHRS N/A
- NVGS $583,931,000.00
- Revenue This Year
- GHRS N/A
- NVGS $3.45
- Revenue Next Year
- GHRS N/A
- NVGS N/A
- P/E Ratio
- GHRS N/A
- NVGS $11.46
- Revenue Growth
- GHRS N/A
- NVGS 6.38
- 52 Week Low
- GHRS $6.00
- NVGS $10.55
- 52 Week High
- GHRS $20.50
- NVGS $18.18
- Technical
- Relative Strength Index (RSI)
- GHRS 52.59
- NVGS 51.97
- Support Level
- GHRS $11.50
- NVGS $14.03
- Resistance Level
- GHRS $12.94
- NVGS $14.90
- Average True Range (ATR)
- GHRS 0.98
- NVGS 0.35
- MACD
- GHRS -0.14
- NVGS -0.03
- Stochastic Oscillator
- GHRS 32.73
- NVGS 37.50
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.